Showing 1 - 15 results of 15 for search 'Arnold G Vulto', query time: 0.03s
Refine Results
-
1
Biologicals and Biosimilars in Hematology: The Case of Rituximab by Arnold G. Vulto
Published 2019-12-01
Article -
2
-
3
-
4
-
5
-
6
Economic evaluation of biosimilars for reimbursement purposes – what, when, how? by Evelien Moorkens, Hannah Broux, Isabelle Huys, Arnold G. Vulto, Steven Simoens
Published 2020-01-01
Article -
7
-
8
-
9
-
10
-
11
-
12
Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany by Evelien Moorkens, Teresa Barcina Lacosta, Arnold G. Vulto, Martin Schulz, Gabriele Gradl, Salka Enners, Gisbert Selke, Isabelle Huys, Steven Simoens
Published 2020-10-01
Article -
13
Sustainability of Biosimilars in Europe: A Delphi Panel Consensus with Systematic Literature Review by Arnold G. Vulto, Jackie Vanderpuye-Orgle, Martin van der Graaff, Steven R. A. Simoens, Lorenzo Dagna, Richard Macaulay, Beenish Majeed, Jeffrey Lemay, Jane Hippenmeyer, Sebastian Gonzalez-McQuire
Published 2020-11-01
Article -
14
IGF2-tagging of GAA promotes full correction of murine Pompe disease at a clinically relevant dosage of lentiviral gene therapy by Qiushi Liang, Fabio Catalano, Eva C. Vlaar, Joon M. Pijnenburg, Merel Stok, Yvette van Helsdingen, Arnold G. Vulto, Ans T. van der Ploeg, Niek P. van Til, W.W.M. Pim Pijnappel
Published 2022-12-01
Article -
15
Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi s... by Daniel Aletaha, Katerina Chatzidionysiou, Alfons A den Broeder, Paco M J Welsing, Rieke Alten, Bart van den Bemt, Denis Mulleman, James Galloway, John Isaac, P Verschueren, Arnold G Vulto, Céleste J T van der Togt, Lise Verhoef
Published 2023-03-01
Article